Calton & Associates’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,538
Closed -$83K 350
2021
Q4
$83K Sell
1,538
-79
-5% -$5.31K 0.02% 360
2021
Q3
$111K Buy
1,617
+3
+0.2% +$213 0.02% 387
2021
Q2
$146K Sell
1,614
-21
-1% -$1.82K 0.03% 393
2021
Q1
$152K Buy
+1,635
New +$183K 0.03% 384
2020
Q4
Sell
-1,519
Closed -$71K 383
2020
Q3
$71K Buy
+1,519
New +$144K 0.01% 337
2020
Q2
Sell
-132
Closed -$14K 333
2020
Q1
$14K Sell
132
-9
-6% -$1.61K ﹤0.01% 304
2019
Q4
$36K Sell
141
-55
-28% -$20.5K 0.01% 356
2019
Q3
$103K Buy
196
+44
+29% +$32.6K 0.02% 334
2019
Q2
$143K Buy
152
+15
+11% +$15.1K 0.04% 273
2019
Q1
$149K Buy
+137
New +$123K 0.05% 248

Other funds holding ACB

Calton & Associates's ACB Position: Q1 2022 in Review

Calton & Associates sold out of Aurora Cannabis (ACB) in Q1 2022, closing a stake of 1,538 shares — an estimated $83K sold.

Calton & Associates first reported a position in ACB in Q1 2019 and held it in 10 quarters. The position peaked at $152K in Q1 2021. 253 funds tracked by Wall St. Rank hold ACB as of Q1 2022.

  • Calton & Associates reported no remaining Aurora Cannabis position as of Q1 2022 after selling out during the quarter.
  • Calton & Associates sold 1,538 Aurora Cannabis shares in Q1 2022, an estimated $83K.
  • Calton & Associates first reported a position in Aurora Cannabis in Q1 2019 and held it in 10 quarters.
  • Calton & Associates's Aurora Cannabis position peaked at $152K in Q1 2021.
  • 253 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2022.

Based on Calton & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.